CNN iReport CNN iReport

Osteoporosis Drug FDA Approved To Prevent New Fractures

July 10, 2008 | New York, New York | Vetting explained

InsideInfo Posted by:
InsideInfo

  • Viewed 35 times
  • Shared 5 times
 
iReport —

 

The U.S. Food and Drug Administration (FDA) has approved a new once-a-month dose of Actonel, making it the only oral once-a-month osteoporosis therapy approved to help prevent both spinal and non-spinal fractures in postmenopausal women.

 

 

The new once-a-month dose is now available for patients seeking the fracture protection of Actonel in the convenience of one monthly pill.  In addition to being approved to help protect the spine from fractures, Actonel is also approved to help prevent non-spinal fractures, measured as a group, namely the hip, wrist, collar bone, arm, pelvis, and leg.

 

 

Comments

Log in to comment

iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.

What is iReport?

  • Share

    Tell a story, offer an opinion, say what's important to you.

  • Discuss

    Join the conversation on the day's big issues.

  • Be heard

    The best iReports get vetted and used on CNN platforms.

iReport is a user-generated section of CNN.com. The stories here come from users. CNN has vetted only the stories marked with the "CNN" badge. MORE...